25 7月 2019 by admin in UncategorizedComments Syros to Report Second Quarter 2019 Financial Results on Thursday, August 1, 2019
23 7月 2019 by admin in UncategorizedComments resTORbio Announces Early Completion of Enrollment of Phase 3 PROTECTOR 1 Trial with RTB101 in Clinically Symptomatic Respiratory Illness
23 7月 2019 by admin in UncategorizedComments Crescendo Biologics’ second oncology-targeted Humabody® licensed by Takeda
